The Association of Active Cancer With Venous Thromboembolism Location: A Population-Based Study
- Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Maraveyas, A.; Johnson, M. // British Journal of Cancer;6/16/2009, Vol. 100 Issue 12, p1837
After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is still limited. Limitations can be related to...
- Scoring system stratified patients by recurrence risk of cancer-associated VTE. Cowles, Carey; Fisher, Stacey L.; Harris, Jason // Hem/Onc Today;12/25/2010, Vol. 11 Issue 24, p30
The article reports on a scoring system that was able to stratify patients by recurrence risk of cancer-associated venous thromboembolism (VTE).
- Venous Thromboembolism and Cancer. Karpman, Harold L. // Internal Medicine Alert;10/29/2008, Vol. 30 Issue 20, p171
The article presents a study which found that previously undiagnosed cancer occurs mostly in patients with an unprovoked venous thromboembolism (VTE) and is more often discovered with an extensive cancer screening technique compared to a limited screening technique.
- Extended duration VTE prophylaxis in cancer patients. Lohr, Lisa K. // Hem/Onc Today;8/25/2009, Vol. 10 Issue 16, p6
This article explores the effectiveness of extended venous thromboembolism prophylaxis in cancer patients.
- Cystectomy Patients May Need Longer VTE Prophylaxis. // Renal & Urology News;Dec2013, Vol. 12 Issue 12, p16
The article reports on a study by Amanda A. VanDlac and colleagues which finds that patients undergoing radical cystectomy for bladder cancer may need longer pharmacologic prophylaxis for venous thromboembolism (VTE).
- Population health in transition. Caldwell., John C. // Bulletin of the World Health Organization;2001, Vol. 79 Issue 2, p159
Analyzes Abdel R. Omran's paper 'The Epidemologic Transition: A Theory of the Epidemiology of Population Change,' published in a 1971 edition of the 'Milbank Memorial Fund Quarterly.' Strength of Omran's arguments; Impact of the assay on the public health community; Similarities to 'The First...
- Cancer survival: United States and Ontario. // JNCI: Journal of the National Cancer Institute;8/17/94, Vol. 86 Issue 16, p1192
Reports on relative survival rates for cancer patients in Ontario and the United States. Hodgkin's disease; Colonic cancer; Lung cancer; Breast cancer; Differences as a reflection of more effective treatment or bias resulting from differences in diagnostic and screening practices.
- VTE substantial burden in cancer patients. // PharmacoEconomics & Outcomes News;Mar2015, Vol. 723 Issue 1, p30
The article discusses research being done on the cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France, which references a study published in the February 26, 2015 issue of "Advances in Therapy."
- Serum Cardiolipin Antibodies in Cancer Patients with Thromboembolic Events. Özgüroglu, Mustafa; Arun, Banu; Erzin, Yusuf; Demir, Gökhan; Demirelli, Fuat; Mandel, Nil Molinas; Büyükünal, Evin; Serdengeçti, Süheyla; Berkarda, Bülent // Clinical & Applied Thrombosis/Hemostasis;Jul1999, Vol. 5 Issue 3, p181
This study was undertaken to investigate a possible association of anticardiolipin antibodies (ACLAs) in cancer patients with thromboembolic events. Twenty-five patients with solid tumors complicated with acute thrombosis, 36 cancer patients without any thrombotic events, and a group of 20...